Viewing Study NCT00564928


Ignite Creation Date: 2025-12-26 @ 10:37 AM
Ignite Modification Date: 2026-02-02 @ 12:34 PM
Study NCT ID: NCT00564928
Status: COMPLETED
Last Update Posted: 2012-12-11
First Post: 2007-11-27
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase 2 Study to Investigate the Clinical Activity of IPI-504 in Patients With Hormone-resistant Prostate Cancer
Sponsor: Infinity Pharmaceuticals, Inc.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2007-11
Start Date Type: None
Primary Completion Date: 2010-03
Primary Completion Date Type: ACTUAL
Completion Date: 2010-07
Completion Date Type: ACTUAL
First Submit Date: 2007-11-27
First Submit QC Date: None
Study First Post Date: 2007-11-29
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: 2012-12-10
Disp First Post Date Type: ESTIMATED
Last Update Submit Date: 2012-12-07
Last Update Post Date: 2012-12-11
Last Update Post Date Type: ESTIMATED